Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
OLMA.OQ - Olema Pharmaceuticals Inc
Olema Pharmaceuticals Inc at Citi Oncology Leadership Summit (Virtual)
Feb 19, 2026 / 06:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right. Welcome everyone, to the next session. This is day two of CITI's Virtual Oncology Summit. I'm Miguel Naimovitz, biotech analyst here at City in New York. Remember, if you have questions, for our speaker, who is, Sean Bone, the CEO of Alima, and we'll start the conversation in a moment. If you have questions for him, just email me and I will, relay them over. Sure. So, Sean, thank you so much. Welcome. I appreciate the time. A lot going on in the world of breast cancer, as you know. A lot to discuss. But before we get to all of that stuff, maybe just, for the, for those a little bit less familiar with Alima, give us the high-level overview of the company. Tell us a little about Palzestrin.

